Biopharmaceutical companies have largely accepted a certain level ofproduct losswhen managing drug substances in single-use systems - unaware that solutions exist to streamline process steps and dramatically diminish product loss . The breaking of single-use bags in turn meansloss of very valuable drug substances.
A global biotechnology company produces different drug substances of highly valuables monoclonal antibodies (mABs). The company experienced a product loss rate between 0.5% and 5% due to the sensitivity of single-use bioprocess containers at sub-zero temperatures. Therefore, the goal was to reduce the current product loss below 0.5%.
This case study discloses how the implementation of RoSS® technologies from Single Use Support had an impact on the product loss during trials of hundreds of single-use bags.
You will be surprised of the cost savings due to reduced product loss.
RoSS shell - Cost efficiency - Case Study
With the implementation of RoSS® shells, a multinational CDMO has been able to standardize its fluid management process thanks to the protective shell’s bag-independence to save operational expenditures. Read how much.
Claus Exenberger is Technical Product Owner at Single Use Support. As product owner of freeze and thaw plaforms and the RoSS shell, the secondary packaging of single-use bags, Claus and his team develops further products that advance handling and freezing of single-use bags and bottles for the biopharmaceutical industry. With his working experience of 7+ years at Single Use Support he is expert in the protection of all available single-use bioprocess containers. His proximity to customers helps connect his process-oriented approach with the technical development of products.
Choosing a selection results in a full page refresh.
